CLINICAL_TRIALS
trial_result
· 2014-08-05
Clinical Trial Update: Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure [Phase 2]
Summary
Phase 2 clinical trial evaluating hemodynamic responses to RLX030 infusion in subjects with acute heart failure has completed; the report summarizes observed he…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure | Phase 2 | Status: COMPLETED